NCT07292792 The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
| NCT ID | NCT07292792 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | HIV Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2026-11-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-21 with a primary completion date of 2026-11-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This 18-month study, "Integration of peer health navigation into comprehensive re-entry services: improving PrEP implementation for justice-involved individuals," aims to increase PrEP awareness and uptake among people with a history of justice involvement in Dallas, primarily clients of Unlocking Doors.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older 2. Client of Unlocking Doors 3. Able to provide informed consent 4. Willing to participate in discussions about general health, sexual health, HIV prevention, and PrEP 5. Willing to complete health screening and eligibility assessment 6. For qualitative interview participants: * Unlocking Doors staff, clients, or PrEP providers who agree to participate in a one-time interview. Exclusion Criteria: 1. Under 18 years of age 2. Unable to provide informed consent 3. Not receiving services at Unlocking Doors 4. Non-English speakers 5. Diagnosed with HIV 6. Incarcerated individuals at the time of recruitment
Contact & Investigator
Ank E Nijhawan, MD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT07292792 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying HIV Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07292792 currently recruiting?
Yes, NCT07292792 is actively recruiting participants. Contact the research team at Laura.Hansen@UTSouthwestern.edu for enrollment information.
Where is the NCT07292792 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07292792 clinical trial?
NCT07292792 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Ank E Nijhawan, MD at University of Texas Southwestern Medical Center. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.